Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2000
12/05/2000US6156306 Administering nucleic acid encoding adenovirus; genetic engineering
12/05/2000US6156305 Implanted tumor cells for the prevention and treatment of cancer
12/05/2000US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
12/05/2000CA1341151C Osmotic agents form peritoneal dialysis
12/05/2000CA1341150C Amplifying the expression of recombinant dna products
12/05/2000CA1341149C Insulin receptor
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071693A2 Method for selecting improved vectors
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071157A2 New vaccine formulations - 1
11/30/2000WO2000071156A2 New vaccine formulations-3
11/30/2000WO2000071155A2 New vaccine formulations - 2
11/30/2000WO2000071142A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071139A2 Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
11/30/2000WO2000071138A2 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000WO2000070972A1 New composition
11/30/2000WO2000049892A3 Dietetic supplement from human placenta
11/30/2000WO2000047719A3 Maturation of dendritic cells with immune response modifying compounds
11/30/2000WO2000046355A3 Telomerase reverse transcriptase transcriptional regulatory sequences
11/30/2000WO2000043499A3 ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
11/30/2000WO2000040269A3 Pharmaceutical compositions for treatment of diseased tissues
11/30/2000WO2000032520A9 Method for activating water and use of activated water of this type
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000011946A3 Prolonged storage of red blood cells
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374938A1 Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
11/30/2000CA2374937A1 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2371356A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/29/2000EP1055372A2 A method of treating colostrum
11/29/2000EP1054988A1 Anti-viral vectors
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054955A2 Compositions comprising viruses and methods for concentrating virus preparations
11/29/2000EP1054954A1 Development of regulatory cells as a means for treating autoimmune disease
11/29/2000EP1054680A1 Composition and method for the treatment of bladder cancer
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000CN1275055A Food supplement composition based on dehydrated crab meat
11/29/2000CN1274603A Externally-used arthralgia treating medicine and its preparation
11/29/2000CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism
11/29/2000CN1274601A Immunity-strengthening and infection-preventing medicine
11/29/2000CN1274599A Cancer treating medicine and its preparation
11/29/2000CN1274597A Hyperosteogeny treating medicine
11/29/2000CN1274596A Compound bee venom liniment and its preparation
11/29/2000CN1274592A Enterogastric disease treating medicine and its preparation
11/29/2000CN1274590A Plaster for treating hyperosteogeny and protrusion of lumber ertebral disc
11/29/2000CN1274588A Composite thrombolytic medicine
11/29/2000CN1274587A Cancer treating Chinese medicine
11/29/2000CN1274585A Kuiyangling as one kind of Chinese medicine for gastroenteritic diseases
11/29/2000CN1274584A Application of photosynthetic bacteria as medical health article and its production process and product
11/29/2000CN1274533A Serial tea beverage with gelatin
11/29/2000CN1058993C Prepn. and use of molecular chimera for treatment of cancer
11/29/2000CN1058991C Hematopoietic facilitatory cells
11/29/2000CN1058902C Medical liquid for invigorating kidney Yang
11/29/2000CN1058900C Paste for treating face skin ulcer and method for preparing same
11/29/2000CN1058893C Medicine for treating woman's dysmenorrhea and preparing process thereof
11/29/2000CN1058891C Medicine for treating child asthma type bronchitis
11/29/2000CN1058890C Chinese medicine powder for curing gastroenteritis
11/29/2000CN1058889C External-use ointment for treating atrophic arthritis
11/29/2000CN1058888C External-use ointment for treating pathological changes of intervertebral disc
11/29/2000CN1058886C Oral medicine for treatment of acne
11/29/2000CN1058884C Effective medicine composition for treatment of rheumatism and its capsule
11/29/2000CN1058883C Chinese medicine preparation for treatment of bronchial asthma
11/29/2000CN1058872C Method of producing medicine for treatment of chronic osteomyelitis
11/29/2000CN1058871C Tianjianwan and its producing process
11/29/2000CN1058867C Drug composition for curing bone tuberculosis in fumigation
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153428 α(1,3) galactosyltransferase negative porcine cells
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153228 Propolis extract
11/28/2000US6153227 Reducing the odor by soaking propolis in a hydrophilic solvent, e.g., methanol, to effect extraction followed by treating the liquid layer with an anion exchange resin; without attenuating the inherent biological activities
11/28/2000US6153226 Viricidal composition comprising a synergistic mixture of a phenol component and propolis; the phenol is a mono- or polyhydroxylated compound comprising a nonfused or fused benzene ring
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6153184 Contacting, by ductal cannulation, the ductal epithelium of the exocrine gland with a cytolytic virus to destroy less than all of the ductal epithelium so as to inhibit formation of cancer of ductal epithelial origin
11/28/2000US6152964 Method for in vitro production of bone
11/28/2000US6152142 Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
11/27/2000CA2310218A1 A composition and method for treating bacterial infection
11/25/2000CA2309226A1 A method of treating colostrum
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070024A2 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
11/23/2000WO2000070022A2 Ex vivo expansion of mammalian hematopoietic stem cells
1 ... 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 ... 1259